Trauma Monthly

Published by: Kowsar

Sulfur Mustard Exposure and Cardiovascular Effects: A Review

Reza Karbasi-Afshar 1 , Mahyar Mohammadifard 2 , Nahid Azdaki 2 , Parvin Rahnama 3 , Amin Saburi 1 , 2 , * and Mostafa Ghanei 1 , *
Authors Information
1 Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Atherosclerosis and Coronary Artery Research Center, Birjand University of Medical Sciences, Birjand, IR Iran
3 Department of Midwifery, Shahed University, Tehran, IR Iran
Corresponding Authors:
Article information
  • Trauma Monthly: March 2017, 22 (2); e34011
  • Published Online: September 24, 2016
  • Article Type: Review Article
  • Received: October 23, 2015
  • Revised: August 1, 2016
  • Accepted: September 17, 2016
  • DOI: 10.5812/traumamon.34011

To Cite: Karbasi-Afshar R, Mohammadifard M, Azdaki N, Rahnama P, Saburi A, et al. Sulfur Mustard Exposure and Cardiovascular Effects: A Review, Trauma Mon. 2017 ; 22(2):e34011. doi: 10.5812/traumamon.34011.

Abstract
Copyright © 2016, Trauma Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Conclusion
Acknowledgements
Footnote
References
  • 1. Senkus E, Jassem J. Cardiovascular effects of systemic cancer treatment. Cancer Treat Rev. 2011; 37(4): 300-11[DOI][PubMed]
  • 2. Ghanei M, Harandi AA. Long term consequences from exposure to sulfur mustard: a review. Inhal Toxicol. 2007; 19(5): 451-6[DOI][PubMed]
  • 3. Gholamrezanezhad A, Saghari M, Vakili A, Mirpour S, Farahani MH. Myocardial perfusion abnormalities in chemical warfare patients intoxicated with mustard gas. Int J Cardiovasc Imaging. 2007; 23(2): 197-205[DOI][PubMed]
  • 4. Pishgoo B, Ghanei M, Harandi AA, Farahani MM, Daadjoo Y. Long term cardiac abnormality after single high dose exposure to sulfur mustard? Indian Heart J. 2007; 59(2): 181-4[PubMed]
  • 5. Rohani A, Akbari V, Moghadam FT. A case control study of cardiovascular health in chemical war disabled Iranian victims. Indian J Crit Care Med. 2010; 14(3): 109-12[DOI][PubMed]
  • 6. Maisonneuve A, Callebat I, Debordes L, Coppet L. Biological fate of sulphur mustard in rat: toxicokinetics and disposition. Xenobiotica. 1993; 23(7): 771-80[PubMed]
  • 7. Shabestari MM, Jabbari F, Gohari B, Moazen N, Azizi H, Moghiman T, et al. Coronary artery angiographic changes in veterans poisoned by mustard gas. Cardiology. 2011; 119(4): 208-13[PubMed]
  • 8. Karbasi-Afshar R, Shahmari A, Madadi M, Poursaleh Z, Saburi A. Coronary angiography findings in lung injured patients with sulfur mustard compared to a control group. Ann Card Anaesth. 2013; 16(3): 188-92[DOI][PubMed]
  • 9. Vanhoutte PM. Regeneration of the endothelium in vascular injury. Cardiovasc Drugs Ther. 2010; 24(4): 299-303[DOI][PubMed]
  • 10. Madonna R, De Caterina R. Cellular and molecular mechanisms of vascular injury in diabetes--part II: cellular mechanisms and therapeutic targets. Vascul Pharmacol. 2011; 54(3-6): 75-9[DOI][PubMed]
  • 11. Madonna R, De Caterina R. Cellular and molecular mechanisms of vascular injury in diabetes--part I: pathways of vascular disease in diabetes. Vascul Pharmacol. 2011; 54(3-6): 68-74[DOI][PubMed]
  • 12. Vanhoutte PM. Endothelial dysfunction: the first step toward coronary arteriosclerosis. Circ J. 2009; 73(4): 595-601[PubMed]
  • 13. Li JJ. Inflammation in coronary artery diseases. Chin Med J (Engl). 2011; 124(21): 3568-75[PubMed]
  • 14. Attaran D, Lari SM, Khajehdaluee M, Ayatollahi H, Towhidi M, Asnaashari A, et al. Highly sensitive C-reactive protein levels in Iranian patients with pulmonary complication of sulfur mustard poisoning and its correlation with severity of airway diseases. Hum Exp Toxicol. 2009; 28(12): 739-45[DOI][PubMed]
  • 15. Rezaian GR, Emad A, Ghayumi MA, Rezaian S, Zare N. Exercise intolerance and chronotropic impairment-The long-term cardiovascular sequelae of mustard gas exposure: A paired-comparative study. Environ Toxicol Pharmacol. 2008; 26(2): 212-5[DOI][PubMed]
  • 16. Aliannejad R, Saburi A, Ghanei M. Cardiopulmonary exercise test findings in symptomatic mustard gas exposed cases with normal HRCT. Pulm Circ. 2013; 3(2): 414-8[DOI][PubMed]
  • 17. Tavakolipour P, Sadeghi M, Heidari R, Vosough AA, Rabiei K. The effect of Sildenafil on the pulmonary artery hypertension caused by mustard gas. J Isfahan Med School. 2008; 26(90)
  • 18. Casanova C, Celli BR, Barria P, Casas A, Cote C, De Torres JP, et al. The 6-min walk distance in healthy subjects: reference standards from seven countries. European Respiratory J. 2011; 37(1): 150-6
  • 19. Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg J, et al. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation. 2001; 104(14): 1694-740[PubMed]
  • 20. Ghanei M, Sheyacy M, Abbasi MA, Ani A, Aslani J. Correlation between the degree of air trapping in chest HRCT and cardiopulmonary exercise test parameters: could HRCT be a predictor of disease severity? Arch Iran Med. 2011; 14(2): 86-90[PubMed]
  • 21. Hefazi M, Attaran D, Mahmoudi M, Balali-Mood M. Late respiratory complications of mustard gas poisoning in Iranian veterans. Inhal Toxicol. 2005; 17(11): 587-92[DOI][PubMed]
  • 22. Tedford RJ, Hassoun PM, Mathai SC, Girgis RE, Russell SD, Thiemann DR, et al. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation. 2012; 125(2): 289-97[DOI][PubMed]
  • 23. Minai OA, Nathan SD, Hill NS, Badesch DB, Stoller JK. Pulmonary hypertension in lung diseases: survey of beliefs and practice patterns. Respir Med. 2010; 104(5): 741-8[DOI][PubMed]
  • 24. Hoeper MM, Andreas S, Bastian A, Claussen M, Ghofrani HA, Gorenflo M, et al. Pulmonary hypertension due to chronic lung disease: updated Recommendations of the Cologne Consensus Conference 2011. Int J Cardiol. 2011; 154 Suppl 1-53[DOI][PubMed]
  • 25. Karami A, Ghanei M, Alaeddini F, Soltanpour MJ, pourali F, Yassini M, et al. Vascular endothelial growth factor in bronchoalveolar lavage fluid in sulfur mustard exposed lung patients. Oman Med J. 2011; 26(2): 118-21[DOI][PubMed]
  • 26. Ghanei M, Eshraghi M, Jalali AR, Aslani J. Evaluation of latent hemoptysis in Sulfur Mustard injured patients. Environ Toxicol Pharmacol. 2006; 22(2): 128-30[DOI][PubMed]
  • 27. Willems JL. Clinical management of mustard gas casualties. Ann Med Mil Belg. 1989; 3: 1-61
  • 28. Momeni AZ, Aminjavaheri M. Skin manifestations of mustard gas in a group of 14 children and teenagers: a clinical study. Int J Dermatol. 1994; 33(3): 184-7[PubMed]
  • 29. Iyriboz Y. A recent exposure to mustard gas in the United States: clinical findings of a cohort (n = 247) 6 years after exposure. MedGenMed. 2004; 6(4): 4[PubMed]
  • 30. Alber HF, Wanitschek MM, de Waha S, Ladurner A, Suessenbacher A, Dorler J, et al. High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography. Eur J Clin Invest. 2008; 38(6): 372-80[DOI][PubMed]
  • 31. Ghodousi K, Ghaniee M, Bahalou HS, Khodami VHR. Body mass index in veterans exposed to chemical warfare agents with chronic bronchiolitis. Iran J Endocrin Metabol. 2007; 9(3): 285-90
  • 32. Schulz R, Grebe M, Eisele HJ, Mayer K, Weissmann N, Seeger W. Obstructive sleep apnea-related cardiovascular disease [ in German ]. Med Klin (Munich). 2006; 101(4): 321-7[DOI][PubMed]
  • 33. Fletcher EC, Schaaf JW, Miller J, Fletcher JG. Long-term cardiopulmonary sequelae in patients with sleep apnea and chronic lung disease. Am Rev Respir Dis. 1987; 135(3): 525-33[DOI][PubMed]
  • 34. Vahedi E, Taheri S, Alaedini F, Poursaleh Z, Ameli J, Ghanei M. Correlations of sleep disorders with severity of obstructive airway disease in mustard gas-injured patients. Sleep Breath. 2012; 16(2): 443-51[DOI][PubMed]
  • 35. Lurie A. Inflammation, oxidative stress, and procoagulant and thrombotic activity in adults with obstructive sleep apnea. Adv Cardiol. 2011; 46: 43-66[DOI][PubMed]
  • 36. Atkeson A, Yeh SY, Malhotra A, Jelic S. Endothelial function in obstructive sleep apnea. Prog Cardiovasc Dis. 2009; 51(5): 351-62[DOI][PubMed]
  • 37. Ghanei M, Harandi AA. Molecular and cellular mechanism of lung injuries due to exposure to sulfur mustard: a review. Inhal Toxicol. 2011; 23(7): 363-71[DOI][PubMed]
  • 38. Auer J, Rammer M, Berent R, Weber T, Lassnig E, Eber B. Relation of C-reactive protein levels to presence, extent, and severity of angiographic coronary artery disease. Indian Heart J. 2002; 54(3): 284-8[PubMed]
  • 39. Chung HY, Lee EK, Choi YJ, Kim JM, Kim DH, Zou Y, et al. Molecular inflammation as an underlying mechanism of the aging process and age-related diseases. J Dent Res. 2011; 90(7): 830-40[DOI][PubMed]
  • 40. Interleukin-6 Receptor Mendelian Randomisation Analysis Consortium . The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet. 2012; 379(9822): 1214-24[DOI][PubMed]
  • 41. Kyriazi E, Tsiotra PC, Boutati E, Ikonomidis I, Fountoulaki K, Maratou E, et al. Effects of adiponectin in TNF-alpha, IL-6, and IL-10 cytokine production from coronary artery disease macrophages. Horm Metab Res. 2011; 43(8): 537-44[DOI][PubMed]
  • 42. Calverley PM, Scott S. Is airway inflammation in chronic obstructive pulmonary disease (COPD) a risk factor for cardiovascular events? COPD. 2006; 3(4): 233-42[PubMed]
  • 43. Aihara K, Ikeda Y, Yagi S, Akaike M, Matsumoto T. Transforming Growth Factor-beta1 as a Common Target Molecule for Development of Cardiovascular Diseases, Renal Insufficiency and Metabolic Syndrome. Cardiol Res Pract. 2010; 2011: 175381[DOI][PubMed]
  • 44. Shohrati M, Ghanei M, Shamspour N, Babaei F, Abadi MN, Jafari M, et al. Glutathione and malondialdehyde levels in late pulmonary complications of sulfur mustard intoxication. Lung. 2010; 188(1): 77-83[DOI][PubMed]
  • 45. Ramprasath T, Murugan PS, Kalaiarasan E, Gomathi P, Rathinavel A, Selvam GS. Genetic association of Glutathione peroxidase-1 (GPx-1) and NAD(P)H:Quinone Oxidoreductase 1(NQO1) variants and their association of CAD in patients with type-2 diabetes. Mol Cell Biochem. 2012; 361(1-2): 143-50[DOI][PubMed]
  • 46. Alamdari DH, Ghayour-Mobarhan M, Tavallaie S, Parizadeh MR, Moohebati M, Ghafoori F, et al. Prooxidant-antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease. Clin Biochem. 2008; 41(6): 375-80[DOI][PubMed]
  • 47. De Rosa S, Cirillo P, Paglia A, Sasso L, Di Palma V, Chiariello M. Reactive oxygen species and antioxidants in the pathophysiology of cardiovascular disease: does the actual knowledge justify a clinical approach? Curr Vasc Pharmacol. 2010; 8(2): 259-75[PubMed]
  • 48. Gonzalez-Salazar A, Molina-Jijon E, Correa F, Zarco-Marquez G, Calderon-Oliver M, Tapia E, et al. Curcumin protects from cardiac reperfusion damage by attenuation of oxidant stress and mitochondrial dysfunction. Cardiovasc Toxicol. 2011; 11(4): 357-64[DOI][PubMed]
  • 49. Panahi Y, Sahebkar A, Amiri M, Davoudi SM, Beiraghdar F, Hoseininejad SL, et al. Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial. Br J Nutr. 2012; 108(7): 1272-9[DOI][PubMed]
  • 50. Ghanei M, Shohrati M, Jafari M, Ghaderi S, Alaeddini F, Aslani J. N-acetylcysteine improves the clinical conditions of mustard gas-exposed patients with normal pulmonary function test. Basic Clin Pharmacol Toxicol. 2008; 103(5): 428-32[DOI][PubMed]
  • 51. Korkmaz A, Kunak ZI, Paredes SD, Yaren H, Tan DX, Reiter RJ. The use of melatonin to combat mustard toxicity. REVIEW. Neuro Endocrinol Lett. 2008; 29(5): 614-9[PubMed]
  • 52. Martens ME, Smith WJ. The role of NAD+ depletion in the mechanism of sulfur mustard-induced metabolic injury. Cutan Ocul Toxicol. 2008; 27(1): 41-53[DOI][PubMed]
  • 53. Lee S, Park Y, Zuidema MY, Hannink M, Zhang C. Effects of interventions on oxidative stress and inflammation of cardiovascular diseases. World J Cardiol. 2011; 3(1): 18-24[DOI][PubMed]
  • 54. Gould NS, White CW, Day BJ. A role for mitochondrial oxidative stress in sulfur mustard analog 2-chloroethyl ethyl sulfide-induced lung cell injury and antioxidant protection. J Pharmacol Exp Ther. 2009; 328(3): 732-9[DOI][PubMed]
  • 55. Zebrack JS, Muhlestein JB, Horne BD, Anderson JL. C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol. 2002; 39(4): 632-7[PubMed]
  • 56. Jafari M, Ghanei M. Evaluation of plasma, erythrocytes, and bronchoalveolar lavage fluid antioxidant defense system in sulfur mustard-injured patients. Clin Toxicol (Phila). 2010; 48(3): 184-92[DOI][PubMed]
  • 57. Coughlin SS. Post-traumatic Stress Disorder and Cardiovascular Disease. Open Cardiovasc Med J. 2011; 5: 164-70[DOI][PubMed]
  • 58. Hashemian F, Khoshnood K, Desai MM, Falahati F, Kasl S, Southwick S. Anxiety, depression, and posttraumatic stress in Iranian survivors of chemical warfare. JAMA. 2006; 296(5): 560-6[DOI][PubMed]
  • 59. Mohaghegh-Motlagh SJ, Arab A, Momtazi S, Musavi-Nasab SN, Saburi A. Psychological assessment of chemical injured war veterans compared to non-chemical injured war veterans. Asia-Pacific Psychy. 2012; 4(3): 189-94[DOI]
  • 60. Man SF, Van Eeden S, Sin DD. Vascular risk in chronic obstructive pulmonary disease: role of inflammation and other mediators. Can J Cardiol. 2012; 28(6): 653-61[DOI][PubMed]
  • 61. Falk JA, Kadiev S, Criner GJ, Scharf SM, Minai OA, Diaz P. Cardiac disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008; 5(4): 543-8[DOI][PubMed]
  • 62. Darchini-Maragheh E, Nemati-Karimooy H, Hasanabadi H, Balali-Mood M. Delayed neurological complications of sulphur mustard and tabun poisoning in 43 Iranian veterans. Basic Clin Pharmacol Toxicol. 2012; 111(6): 426-32[DOI][PubMed]
  • 63. Hassan ZM, Ebtekar M, Ghanei M, Taghikhani M, Noori Daloii MR, Ghazanfari T. Immunobiological consequences of sulfur mustard contamination. Iran J Allergy Asthma Immunol. 2006; 5(3): 101-8[PubMed]
  • 64. Jin X, Ray R, Leng Y, Ray P. Molecular determination of laminin-5 degradation: a biomarker for mustard gas exposure diagnosis and its mechanism of action. Exp Dermatol. 2008; 17(1): 49-56[DOI][PubMed]
  • 65. Ekstrand-Hammarstrom B, Wigenstam E, Bucht A. Inhalation of alkylating mustard causes long-term T cell-dependent inflammation in airways and growth of connective tissue. Toxicology. 2011; 280(3): 88-97[DOI][PubMed]
  • 66. Watz H, Waschki B, Meyer T, Kretschmar G, Kirsten A, Claussen M, et al. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest. 2010; 138(1): 32-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments